share

Cytochrome P450 14A-Demethylase Inhibitor 1D CAS NO 1155361-02-6


Unit Price:

CAS No.:1155361-02-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Cytochrome P450 14A-Demethylase Inhibitor 1D is a potent and selective small molecule inhibitor targeting the CYP51 enzyme, a key component in the ergosterol biosynthesis pathway. This compound is of significant value for researchers investigating fungal biology, antifungal drug resistance mechanisms, and for use as a biochemical tool in high-throughput screening assays. It is primarily needed by pharmaceutical R&D teams, academic research institutions, and biotechnology companies focused on developing novel antifungal agents and studying sterol metabolism.

Application

  • Antifungal Research & Development: Serves as a critical biochemical tool for studying the mechanism of action of azole-class antifungal drugs and for screening new candidate compounds.
  • Biochemical Pathway Analysis: Used to specifically inhibit CYP51 (14α-demethylase) in vitro to elucidate its role in ergosterol synthesis and membrane integrity in fungi and protozoa.
  • Drug Resistance Studies: Essential for investigating mutations in the CYP51 gene that confer resistance to clinical antifungal agents like fluconazole and itraconazole.
  • High-Throughput Screening (HTS): Employed as a reference standard or positive control in cell-based and enzymatic assays designed to discover new CYP51 inhibitors.
  • Parasitology Research: Applied in studies targeting Trypanosoma and Leishmania species, which utilize similar sterol biosynthesis pathways, for potential antiparasitic drug discovery.

Basic Information

Product Name Cytochrome P450 14A-Demethylase Inhibitor 1D
CAS No. 1155361-02-6
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms CYP51 Inhibitor 1D; 14α-Demethylase Inhibitor 1D; Sterol 14α-Demethylase Inhibitor; Lanosterol 14α-Demethylase Inhibitor; Antifungal Research Compound 1155361-02-6; CYP Inhibitor Screening Tool; Azole Synergy Research Compound
EINECS Contact for details

Quality Control

Our Cytochrome P450 14A-Demethylase Inhibitor 1D is produced under strict quality management protocols to ensure batch-to-batch consistency and reliability for sensitive research applications. Each lot undergoes comprehensive analytical characterization, including purity verification by HPLC and structural confirmation. A detailed Certificate of Analysis (COA) documenting identity, purity, and assay results is provided with every shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at 2-8°C or as indicated on the product label or COA. For long-term storage, keep desiccated at -20°C. Allow the product to equilibrate to room temperature before opening to prevent moisture condensation.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Purity (HPLC) ≥ 95%
Water Content (KF) ≤ 1.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.